Key stats
About KOREA INVESTMENT MANAGEMENT CO. LTD KIM ACE GLOBAL BIG PHARMA ETF
Home page
Inception date
Nov 19, 2024
Replication method
Synthetic
Dividend treatment
Distributes
Primary advisor
Korea Investment Management Co., Ltd.
ISIN
KR7497510008
KIM ACE Global Big Pharma ETF is an exchange-traded fund incorporated in South Korea. The objective of the fund is to achieve return that closely replicates the performance of Solactive Global Big Pharma Index PR
Related funds
Classification
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
497510 trades at 9,280 KRW today, its price has fallen −1.43% in the past 24 hours. Track more dynamics on 497510 price chart.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
497510 expense ratio is 0.30%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.
No, 497510 isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, 497510 technical analysis shows the strong sell rating and its 1-week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating 497510 shows the strong sell signal. See more of 497510 technicals for a more comprehensive analysis.
Today, 497510 technical analysis shows the strong sell rating and its 1-week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating 497510 shows the strong sell signal. See more of 497510 technicals for a more comprehensive analysis.
Yes, 497510 pays dividends to its holders with the dividend yield of 0.00%.
497510 shares are issued by Korea Investment Holdings Co., Ltd.
497510 follows the Solactive Global Big Pharma Index - Benchmark Price Return. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund started trading on Nov 19, 2024.
The fund's management style is passive, meaning it's aiming to replicate the performance of the underlying index by holding assets in the same proportions as the index. The goal is to match the index's returns.